|
Apr 30
|
Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update
|
|
Apr 12
|
Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?
|
|
Apr 4
|
Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma
|
|
Mar 12
|
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
|
|
Mar 7
|
Rigel Pharmaceuticals Inc (RIGL) Reports Growth in 2023 Sales, Despite Net Loss for the Year
|
|
Mar 7
|
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcript
|
|
Mar 6
|
Q4 2023 Rigel Pharmaceuticals Inc Earnings Call
|
|
Mar 6
|
Owning 47% shares,institutional owners seem interested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL),
|
|
Mar 5
|
Rigel Pharmaceuticals (RIGL) Reports Break-Even Earnings for Q4
|
|
Mar 5
|
Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
|
Jan 15
|
When Will Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Become Profitable?
|
|
Jan 5
|
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
|
|
Jan 4
|
Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma
|
|
Jan 3
|
Here's Why You Should Bet on Rigel Pharmaceuticals (RIGL) Now
|
|
Jan 3
|
Rigel to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Jan 2
|
Corcept (CORT) Falls on Loss of Korlym Patent Lawsuit to Teva
|
|
Jan 2
|
Eli Lilly (LLY) Stock Up 57% in 2023: Will the Uptrend Continue?
|
|
Dec 18
|
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Stock Catapults 44% Though Its Price And Business Still Lag The Industry
|
|
Dec 12
|
Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders are up 20% this past week, but still in the red over the last three years
|
|
Dec 8
|
Best Momentum Stock to Buy for December 8th
|